MCQ 1
Question: Which of the following is a common symptom of congestive heart failure (CHF)?
A. Hypertension
B. Chest pain
C. Edema
D. Hyperglycemia
E. Hyperlipidemia
Click here to see the answer
Answer: C. Edema
Explanation: Edema, particularly in the lower extremities, is a common symptom of congestive heart failure due to fluid retention.
MCQ 2
Question: What is the primary action of ACE inhibitors in the management of congestive heart failure?
A. Decrease heart rate
B. Increase myocardial contractility
C. Reduce afterload and preload
D. Increase blood pressure
E. Decrease blood glucose levels
Click here to see the answer
Answer: C. Reduce afterload and preload
Explanation: ACE inhibitors help reduce afterload and preload by causing vasodilation and reducing fluid retention, thereby improving cardiac output and symptoms in CHF patients.
MCQ 3
Question: A patient with congestive heart failure is prescribed furosemide. What is the main purpose of this medication in CHF management?
A. To reduce blood pressure
B. To increase heart rate
C. To promote diuresis and reduce fluid overload
D. To decrease myocardial oxygen consumption
E. To control blood glucose levels
Click here to see the answer
Answer: C. To promote diuresis and reduce fluid overload
Explanation: Furosemide is a diuretic used to promote the excretion of excess fluid, thereby reducing fluid overload and symptoms such as edema and shortness of breath in CHF patients.
MCQ 4
Question: Which laboratory test is most useful in monitoring the effectiveness of diuretic therapy in a CHF patient?
A. Complete blood count (CBC)
B. Serum creatinine and electrolytes
C. Liver function tests (LFTs)
D. Hemoglobin A1c
E. Lipid profile
Click here to see the answer
Answer: B. Serum creatinine and electrolytes
Explanation: Monitoring serum creatinine and electrolytes is important to assess kidney function and detect electrolyte imbalances, which are crucial in patients on diuretic therapy for CHF.
MCQ 5
Question: In addition to medication, what lifestyle modification should be recommended to a patient with CHF to help manage their condition?
A. Increase salt intake
B. Decrease physical activity
C. Follow a low-sodium diet
D. Increase fluid intake
E. Avoid all forms of exercise
Click here to see the answer
Answer: C. Follow a low-sodium diet
Explanation: A low-sodium diet helps prevent fluid retention and reduce the workload on the heart, which is beneficial for managing symptoms in patients with CHF.
MCQ 6
Question: What is the role of beta-blockers in the treatment of congestive heart failure?
A. Increase heart rate
B. Reduce myocardial oxygen demand and improve ventricular function
C. Promote diuresis
D. Increase blood pressure
E. Decrease blood glucose levels
Click here to see the answer
Answer: B. Reduce myocardial oxygen demand and improve ventricular function
Explanation: Beta-blockers reduce myocardial oxygen demand, control heart rate, and improve ventricular function, which can help in the long-term management of CHF.
MCQ 7
Question: Which of the following is a potential adverse effect of long-term furosemide use in CHF patients?
A. Hyperkalemia
B. Hyponatremia
C. Hypoglycemia
D. Hypercalcemia
E. Hypernatremia
Click here to see the answer
Answer: B. Hyponatremia
Explanation: Long-term use of furosemide, a diuretic, can lead to electrolyte imbalances such as hyponatremia, which needs to be monitored in CHF patients.
MCQ 8
Question: A patient with CHF is experiencing worsening symptoms despite being on optimal medical therapy. What non-pharmacological intervention might be considered next?
A. Increase fluid intake
B. Cardiac resynchronization therapy (CRT)
C. High-sodium diet
D. Decrease physical activity
E. Hyperbaric oxygen therapy
Click here to see the answer
Answer: B. Cardiac resynchronization therapy (CRT)
Explanation: Cardiac resynchronization therapy (CRT) is a non-pharmacological intervention that can improve symptoms and outcomes in patients with CHF who have not responded adequately to optimal medical therapy.
MCQ 9
Question: Which medication is commonly used to provide symptomatic relief in acute decompensated heart failure by reducing preload?
A. Metoprolol
B. Digoxin
C. Nitroglycerin
D. Lisinopril
E. Spironolactone
Click here to see the answer
Answer: C. Nitroglycerin
Explanation: Nitroglycerin is used in acute decompensated heart failure to provide symptomatic relief by reducing preload through venodilation, thereby improving symptoms such as dyspnea.
MCQ 10
Question: What is a common side effect of spironolactone, a potassium-sparing diuretic used in CHF?
A. Hypokalemia
B. Hyperkalemia
C. Hypernatremia
D. Hypocalcemia
E. Hyponatremia
Click here to see the answer
Answer: B. Hyperkalemia
Explanation: Spironolactone is a potassium-sparing diuretic that can lead to hyperkalemia, which requires monitoring in patients with CHF.
MCQ 11
Question: Which drug combination is known as an angiotensin receptor-neprilysin inhibitor (ARNI) used in CHF management?
A. Lisinopril and hydrochlorothiazide
B. Losartan and amlodipine
C. Sacubitril and valsartan
D. Metoprolol and furosemide
E. Digoxin and spironolactone
Click here to see the answer
Answer: C. Sacubitril and valsartan
Explanation: Sacubitril and valsartan make up an angiotensin receptor-neprilysin inhibitor (ARNI), which is used to reduce the risk of cardiovascular death and hospitalization in patients with chronic heart failure.
MCQ 12
Question: What is the primary therapeutic action of ivabradine in the management of CHF?
A. Reduces afterload
B. Increases contractility
C. Reduces heart rate by inhibiting the If current in the sinoatrial node
D. Promotes diuresis
E. Lowers blood pressure
Click here to see the answer
Answer: C. Reduces heart rate by inhibiting the If current in the sinoatrial node
Explanation: Ivabradine works by specifically inhibiting the If current in the sinoatrial node, which reduces heart rate without affecting contractility, making it beneficial in CHF management.
MCQ 13
Question: Which of the following is a key benefit of using an ARNI (e.g., sacubitril/valsartan) in CHF patients compared to ACE inhibitors?
A. Lower risk of hyperkalemia
B. Lower risk of angioedema
C. Improved reduction in the risk of cardiovascular death and hospitalization
D. Increased diuretic effect
E. Enhanced blood pressure control
Click here to see the answer
Answer: C. Improved reduction in the risk of cardiovascular death and hospitalization
Explanation: Studies have shown that ARNIs like sacubitril/valsartan provide a greater reduction in the risk of cardiovascular death and hospitalization for heart failure compared to ACE inhibitors alone.
MCQ 14
Question: Which patient population should be monitored closely for bradycardia when using ivabradine for CHF management?
A. Patients with diabetes
B. Patients with hypertension
C. Patients with atrial fibrillation
D. Patients with resting heart rate below 60 bpm
E. Patients with chronic kidney disease
Click here to see the answer
Answer: D. Patients with resting heart rate below 60 bpm
Explanation: Ivabradine can cause bradycardia, so patients with a resting heart rate below 60 bpm should be monitored closely to avoid excessive slowing of the heart rate.
MCQ 15
Question: What is a significant contraindication for the use of sacubitril/valsartan in CHF patients?
A. History of angioedema related to ACE inhibitor or ARB therapy
B. Hyperlipidemia
C. Type 2 diabetes mellitus
D. Controlled hypertension
E. Chronic obstructive pulmonary disease (COPD)
Click here to see the answer
Answer: A. History of angioedema related to ACE inhibitor or ARB therapy
Explanation: Sacubitril/valsartan is contraindicated in patients with a history of angioedema related to previous ACE inhibitor or ARB therapy due to the risk of recurrence.
MCQ 16
Question: Which class of drugs is ivabradine most likely to be combined with for the treatment of CHF?
A. Diuretics
B. Beta-blockers
C. Calcium channel blockers
D. Anticoagulants
E. Statins
Click here to see the answer
Answer: B. Beta-blockers
Explanation: Ivabradine is often used in combination with beta-blockers to further reduce heart rate in patients with CHF who remain symptomatic despite beta-blocker therapy alone.
MCQ 17
Question: Which of the following is a hallmark symptom of left-sided heart failure?
A. Peripheral edema
B. Hepatomegaly
C. Pulmonary congestion
D. Ascites
E. Jugular venous distension
Click here to see the answer
Answer: C. Pulmonary congestion
Explanation: Pulmonary congestion is a hallmark symptom of left-sided heart failure due to the inability of the left ventricle to effectively pump blood, leading to a buildup of fluid in the lungs.
MCQ 18
Question: Which diagnostic test is commonly used to confirm the presence of fluid overload in a patient suspected of having congestive heart failure?
A. Electrocardiogram (ECG)
B. Chest X-ray
C. Complete blood count (CBC)
D. Pulmonary function test (PFT)
E. Magnetic resonance imaging (MRI)
Click here to see the answer
Answer: B. Chest X-ray
Explanation: A chest X-ray is commonly used to confirm the presence of fluid overload and pulmonary congestion in patients suspected of having congestive heart failure.
MCQ 19
Question: Which blood test is used to help diagnose congestive heart failure by measuring the level of a specific peptide released from the heart?
A. Troponin
B. Creatinine
C. B-type natriuretic peptide (BNP)
D. C-reactive protein (CRP)
E. Hemoglobin A1c
Click here to see the answer
Answer: C. B-type natriuretic peptide (BNP)
Explanation: B-type natriuretic peptide (BNP) levels are measured to help diagnose congestive heart failure. Elevated levels indicate increased stress on the heart and are associated with heart failure.
MCQ 20
Question: Which of the following symptoms is indicative of right-sided heart failure?
A. Pulmonary congestion
B. Dyspnea on exertion
C. Orthopnea
D. Peripheral edema
E. Paroxysmal nocturnal dyspnea
Click here to see the answer
Answer: D. Peripheral edema
Explanation: Peripheral edema is indicative of right-sided heart failure due to the inability of the right ventricle to effectively pump blood, leading to fluid buildup in the extremities.
MCQ 21
Question: What is the typical presentation of a patient with congestive heart failure?
A. Sudden onset of severe abdominal pain
B. Chronic cough and wheezing
C. Gradual onset of fatigue, dyspnea, and edema
D. Acute onset of high fever and chills
E. Gradual onset of severe headache and neck stiffness
Click here to see the answer
Answer: C. Gradual onset of fatigue, dyspnea, and edema
Explanation: Patients with congestive heart failure typically present with a gradual onset of symptoms such as fatigue, dyspnea (shortness of breath), and edema due to the heart’s inability to pump blood effectively.
MCQ 22
Question: What symptom is most commonly associated with nocturnal exacerbation in congestive heart failure patients?
A. Diarrhea
B. Night sweats
C. Paroxysmal nocturnal dyspnea
D. Abdominal pain
E. Insomnia
Click here to see the answer
Answer: C. Paroxysmal nocturnal dyspnea
Explanation: Paroxysmal nocturnal dyspnea is a symptom of congestive heart failure where patients experience sudden shortness of breath during the night, leading to awakening and needing to sit up to breathe.
MCQ 23
Question: Which symptom is least likely to be associated with congestive heart failure?
A. Dyspnea
B. Orthopnea
C. Peripheral edema
D. Syncope
E. Nocturia
Click here to see the answer
Answer: D. Syncope
Explanation: While dyspnea, orthopnea, peripheral edema, and nocturia are common symptoms of congestive heart failure, syncope (fainting) is less commonly associated with CHF and may suggest other cardiac or neurological conditions.
*** End of Questions ***